US EPA

2824078 

Journal Article 

Cannabinoid-induced changes in respiration of brain mitochondria 

Fišar, Z; Singh, N; Hroudová, J 

2014 

1 

Toxicology Letters
ISSN: 0378-4274
EISSN: 1879-3169 

231 

1 

62-71 

English 

25195527 

10.1016/j.toxlet.2014.09.002 

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908269088&doi=10.1016%2fj.toxlet.2014.09.002&partnerID=40&md5=7140f820201c760d581007ee1af465bd
Exit
 

Cannabinoids exert various biological effects that are either receptor-mediated or independent of receptor signaling. Mitochondrial effects of cannabinoids were interpreted either as non-receptor-mediated alteration of mitochondrial membranes, or as indirect consequences of activation of plasma membrane type 1 cannabinoid receptors (CB1). Recently, CB1 receptors were confirmed to be localized to the membranes of neuronal mitochondria, where their activation directly regulates respiration and energy production. Here, we performed in-depth analysis of cannabinoid-induced changes of mitochondrial respiration using both an antagonist/inverse agonist of CB1 receptors, AM251 and the cannabinoid receptor agonists, Δ(9)-tetrahydrocannabinol (THC), cannabidiol, anandamide, and WIN 55,212-2. Relationships were determined between cannabinoid concentration and respiratory rate driven by substrates of complex I, II or IV in pig brain mitochondria. Either full or partial inhibition of respiratory rate was found for the tested drugs, with an IC50 in the micromolar range, which verified the significant role of non-receptor-mediated mechanism in inhibiting mitochondrial respiration. Effect of stepwise application of THC and AM251 evidenced protective role of AM251 and corroborated the participation of CB1 receptor activation in the inhibition of mitochondrial respiration. We proposed a model, which includes both receptor- and non-receptor-mediated mechanisms of cannabinoid action on mitochondrial respiration. This model explains both the inhibitory effect of cannabinoids and the protective effect of the CB1 receptor inverse agonist. 

AM251; Anandamide; Cannabidiol; Respiratory rate; WIN 55,212-2; δ⁹-Tetrahydrocannabinol